Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lupin Atlantis
Zug, Zug, Switzerland
- Ownership
- Private
- Development stage
- Other
01
Overview
Lupin Atlantis Holdings SA functions as the European hub of Lupin, an Indian multinational pharmaceutical company. The entity recently expanded its portfolio by acquiring two specialty brands, Aarane (Germany) and Nalcrom (Canada, Netherlands), from Sanofi, with a focus on branded, specialty, and generic pharmaceuticals across a breadth of therapeutic areas[6][8]. Pipeline information specific to the Lupin Atlantis entity is not publicly detailed, but it operates as a key commercial and strategic asset for Lupin's European specialty portfolio.
- Modalities
- Small moleculeBiologicDrug-device combination
- Industry
- Biotech
02
Partnerships
Sanofi (for the acquisition of Aarane and Nalcrom)[6][8]
Beyond the preview
Go deeper on Lupin Atlantis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lupin Atlantis.